A Preliminary Report on Herbal Medicine Use Among Patients Hospitalized at Two-Large COVID-19 Treatment Centers in Uganda
Phillip Musoke,Jerom Okot,Vivien Nanfuka,Pius Rwamafa,Joseph Masajjage,Ivan Kisuule,Brandy Nantaayi,Nelson Ssewante,Felix Bongomin
DOI: https://doi.org/10.2147/RMHP.S339408
2021-11-12
Risk Management and Healthcare Policy
Abstract:Phillip Musoke, 1 Jerom Okot, 2 Vivien Nanfuka, 3 Pius Rwamafa, 4 Joseph Masajjage, 3 Ivan Kisuule, 4 Brandy Nantaayi, 1 Nelson Ssewante, 1 Felix Bongomin 1, 2 1 School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda; 2 Department of Medical Microbiology and Immunology, Faculty of Medicine, Gulu University, Gulu, Uganda; 3 Department of Internal Medicine, Kiruddu National Referral Hospital, Kampala, Uganda; 4 Department of Internal Medicine, Mulago National Referral Hospital, Kampala, Uganda Correspondence: Felix Bongomin Department of Medical Microbiology and Immunology, Faculty of Medicine, Gulu University, P. O. Box, 166, Gulu, Uganda Email Introduction: Herbal medication use among patients with COVID-19 imposes a significant risk of drug-herbal interactions and adverse events. This study aimed to assess the prevalence and factors associated with herbal medicine use among patients hospitalized with COVID-19 attending two large COVID-19 Treatment Units (CTU) in Uganda. Methods: A hospital-based descriptive cross-sectional study was conducted recruiting patients with COVID-19 hospitalized at the Mulago National Referral Hospital and Namboole Stadium CTUs. Chi-square or Fishers' exact test for categorical and Mann–Whitney U -test for numerical were used to determine the association between dependent and independent variables. Results: The study was terminated early because of significant reduction in the number of patients hospitalized with COVID-19 and the closure of Namboole CTU. Of the anticipated 422 participants, we recruited 108 (25.6%). Of this, 58 (53.7%) were female, with a median age of 38 (range: 20– 75) years. Forty-nine (45.4%) had received at least one dose of the COVID-19 vaccine. Fifty-eight (57.3%) of the participants had ever used herbal medicine and the majority had used them in the past 12 months (71.9%, n = 41) either before the diagnosis of COVID-19 (85.4%, n = 35) or after (36.6%, n = 15). Being vaccinated for COVID-19 (adjusted odds ratio (aOR): 3.1, 95% confidence interval (CI): 1.4– 6.8, p = 0.005) and having attained tertiary level of education (aOR: 6.2, 95% CI: 1.7– 23.1, p = 0.006), as well as the accessibility to herbalists (aOR: 31.2, 95% CI: 3.7– 263.2, p = 0.002) were significantly associated with herbal medication use. The majority of participants reported some improvement after using herbal medicine (80.7%, n = 46) and their doctors or nurses asked almost half of the participants about herbal medicine use (49.5%, n = 53). Conclusion: The use of herbal medicines to treat or prevent COVID-19 among hospitalized patients is a widespread practice in Uganda amidst unpublished evidence of their safety and efficacy. Keywords: COVID-19, prevalence, herbal medicine use, Uganda Globally, herbal medicines use has been reported as a common practice both in the prevention and treatment of diseases. 1–3 This is especially common with diseases with high mortality, morbidity or those without conventional therapy that cure the disease. Previous studies in Uganda report that more than 60% of the population depended on traditional medicine before the coronavirus disease (COVID-19) pandemic. 4 Due to the high mortality associated with the second wave of COVID-19, this practice is likely to have increased. Many factors have been identified as drivers of herbal medicine use. In many parts of the world, users have reported that herbal remedies are safe, effective, and are cheap. 1,5 In Uganda, easy access, and cultural familiarity as well as the higher number of traditional health practitioners compared to health-care professionals are some of the common factors influencing this practice. 4,6 A recent study in Uganda reported that media has increased the use of herbal medicines in the treatment and prevention of COVID-19. 7 However, there is limited information concerning the level of herbal medicine use among hospitalized COVID-19 patients and the reasons why they resort to this practice even with the existence of conventional supportive treatment and vaccines. Although some studies have reported the role of combining herbal remedies with westernized medicine in the treatment of COVID-19, 8 the side effects of these remedies are not well studied. This is in addition to the wide variation in the types of herbal medicines on the market which may wrongly influence their use. Various studies have documented harmful consequences of herbal remedies including hepatotoxicity and allergies, which may be worsened by confounders such as self-medication. 1,9 The contin -Abstract Truncated-
health care sciences & services,health policy & services